Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,571,935
-$904,130 QoQ
Shares Held
59,933
-1.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#485
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $293,455,653 across 12 Drug Manufacturers - General names. GILD ranks #9 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
336,097 | $84,575,449 | |
| 2 | JNJ |
Johnson & Johnson
|
258,233 | $65,583,435 | |
| 3 | MRK |
Merck & Co., Inc.
|
447,832 | $57,546,412 | |
| 4 | LLY |
ELI LILLY & Co
|
24,659 | $29,576,746 | |
| 5 | NVS |
Novartis AG
|
79,360 | $12,437,299 | |
| 6 | PFE |
Pfizer Inc
|
465,004 | $11,197,296 | |
| 7 | SNY |
Sanofi
|
195,567 | $8,342,888 | |
| 8 | AMGN |
Amgen Inc
|
21,433 | $7,761,317 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,571,935 | 59,933 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $8,476,065 | 60,817 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,174,078 | 74,744 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,298,915 | 74,765 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,290,969 | 74,781 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,334,503 | 74,382 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,945,946 | 75,197 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,354,820 | 75,797 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $5,619,296 | 81,902 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,728,378 | 91,855 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,497,313 | 92,548 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $7,040,987 | 93,955 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $7,228,318 | 93,789 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,850,289 | 94,616 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $8,103,467 | 94,391 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,828,209 | 143,106 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,800,483 | 126,201 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,871,239 | 132,401 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,882,756 | 177,424 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $23,497,470 | 336,399 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $23,160,647 | 336,344 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $21,091,935 | 326,349 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $652,220 | 11,195 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $808,516 | 12,795 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,142,163 | 27,842 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,695,621 | 36,057 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||